NanoSphere Health Sciences and Vertical Companies™ Form Strategic Partnership to Launch Evolve Products in Arizona & California
NanoSphere Health Sciences Inc. is Nominated for NCIA’s Excellence in Technology Award and Receives OTC Trading Symbo
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation
